- Tytuł:
- First-in-human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS-penetrant soluble guanylyl cyclase stimulator.
- Autorzy:
- Źródło:
- Clinical and translational science [Clin Transl Sci] 2023 Aug; Vol. 16 (8), pp. 1381-1395. Date of Electronic Publication: 2023 May 03.
- Typ publikacji:
- Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Neurodegenerative Diseases*
Humans ; Area Under Curve ; Central Nervous System ; Dose-Response Relationship, Drug ; Double-Blind Method ; Soluble Guanylyl Cyclase ; Vasodilator Agents
Czasopismo naukowe